Placebo for 6QC-ICG clinical trials

SPRAYDYE-Trial - A phase I/II study to assess the efficacy, safety and tolerability of topically applied 6qc-ICG, a cathepsin-activatable fluorescent probe, for real-time intraoperative resection margin assessment in breast conserving surgery

This study looks at a special dye for breast cancer surgery. It's designed to help surgeons see cancer cells more clearly during an operation, aiming to ensure all cancer is removed and reduce the need for more surgery later.